Clinical Trial: A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711158) titled 'A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency' on July 14.

Brief Summary: This is an open-label, multicenter, exploratory Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with congenital coagulation Factor VII deficiency.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Factor VII Deficiency

Intervention: DRUG: SR604

SR604 will be administered as SC injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai RAAS B...